Finch Therapeutics Group Inc (FNCH)

Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted microbiome therapeutics, Finch is advancing a rich pipeline of candidates designed to address a wide range of unmet medical needs. Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. Finch plans to initiate a Phase 3 trial, referred to as PRISM4, as its second pivotal trial of CP101 for recurrent CDI. Finch is also developing CP101 for the treatment of chronic hepatitis B virus, and FIN-211 for the treatment of the gastrointestinal and behavioral symptoms of auti® spectrum disorder. In partnership with Takeda, Finch is advancing FIN-524 and FIN-525 for the treatment of ulcerative colitis and Crohn’s disease, respectively.

Data as of 2021-08-02 09:27:45 -0400
Market Cap624.524 Million Shares Outstanding47.42 Million Avg 30-day Volume78.771 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.2 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low22.5 / 11.56 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) No data
Funds Holding: 36 0 23 (1.35%) No data
13F shares: 6.793 Million 0 4.499 Million No data
% Ownership No data
New Positions: 35 23 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FNCH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FNCH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VINEY JOANNE L.

  • Director
23,419 2021-05-12 1

GRAF SUSAN E

  • Director
23,419 2021-04-23 2

SMISEK JEFFERY A

  • Director
1,694,541 2021-03-23 1

FERRANTE DOMENIC J

  • Director
636,195 2021-03-23 1

HAFT NICHOLAS

  • Director
3,993,057 2021-03-23 1

CRESTOVO INVESTOR LLC

SHUMWAY CHRIS

  • Director
  • 10% Owner
12,641,441 2021-03-23 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 22:15:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 21:45:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 21:15:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 20:45:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 20:15:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 19:45:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 19:15:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 18:45:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 18:15:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 17:45:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 17:15:03 UTC -39.9892 40.0492 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 16:45:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 16:15:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 15:45:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 15:15:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 14:45:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 14:15:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 13:45:03 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 13:15:04 UTC -39.9031 39.9831 35000
FINCH THERAPEUTICS GROUP INC FNCH 2021-08-02 12:45:03 UTC -39.9031 39.9831 35000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments